Results 121 to 130 of about 46,993,701 (406)

Health-risk factors and the prevalence of hypertension: cross-sectional findings from a national cohort of 87 143 Thai Open University Students

, 2015
BACKGROUND: Thailand is undergoing a health-risk transition which increases chronic diseases, particularly hypertension, as a result of a rapid transition from a developing to a developed country.
de Looze, Ferdinandus, Reid, Christopher M, Seubsman, Sam-ang, Sleigh, Adrian, Thai Cohort Study Team, Thawornchaisit, Prasutr   +5 more
core   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

Molecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He, Chiara Testini, Neda Hekmati, Altea Bonello, Aglaia Schiza, Emmanuel Nwadozi, Mia Phillipson, Carina Strell, Michael Welsh   +8 more
wiley   +1 more source

The Millennium Cohort Study.

Population trends, 2002
The Millennium Cohort Study is the latest in the line of British birth cohort studies. MCS resembles its predecessors which follow people born in 1946, 1958 and 1970 in the intention to become multi-purpose longitudinal data resource charting many aspects of individual's lives over time.
Smith, K, Joshi, H
openaire   +2 more sources

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source

Relation of Different Fruit and Vegetable Sources With Incident Cardiovascular Outcomes: A Systematic Review and Meta‐Analysis of Prospective Cohort Studies [PDF]

, 2020
Andreea Zurbau, Fei Au‐Yeung, Sonia Blanco Mejía, Tauseef Khan, Vladimir Vuksan, Elena Jovanovski, Lawrence A. Leiter, Cyril W.C. Kendall, David J.A. Jenkins, John L. Sievenpiper   +9 more
openalex   +1 more source

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

The Lancet, 2023
Chaolin Huang, Lixue Huang, Ye-ming Wang, Xia Li, L. Ren, Xiaoying Gu, Liang Kang, Li Guo, Min Liu, Xing Zhou, Jianfeng Luo, Zhenghui Huang, Shengjin Tu, Yue Zhao, Li Chen, Decui Xu, Yanping Li, Caihong Li, Lu Peng, Yong Li, Wuxiang Xie, D. Cui, L. Shang, Guohui Fan, Jiuyang Xu, Geng Wang, Ying Wang, J. Zhong, Chen Wang, Jianwei Wang, Dingyu Zhang, B. Cao   +31 more
semanticscholar   +1 more source

A cohort profile of the Graham Roberts study cohort

Frontiers in Oncology
PurposeThe Graham Roberts Study was initiated in 2018 and is the first Trials Within Cohorts (TwiCs) study for bladder cancer. Its purpose is to provide an infrastructure for answering a breadth of research questions, including clinical, mechanistic, and supportive care centred questions for bladder cancer patients.ParticipantsAll consented patients ...
Beth Russell, Poppy Leech, Harriet Wylie, Charlotte Louise Moss, Anna Haire, Deborah Enting, Suzanne Amery, Kathryn Chatterton, Muhammad Shamim Khan, Ramesh Thurairaja, Rajesh Nair, Sachin Malde, Kate Smith, Cheryl Gillett, Debra Josephs, Elias Pintus, Sarah Rudman, Simon Hughes, Clare Relton, Mieke Van Hemelrijck   +19 more
openaire   +3 more sources

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Psychosocial twin cohort studies in Japan: the Keio Twin Research Center (KoTReC) [PDF]

, 2019
The Keio Twin Research Center (KoTReC) was established in 2009 at Keio University to combine two longitudinal cohort projects — the Keio Twin Study (KTS) for adolescence and adulthood and the Tokyo Twin Cohort Project (ToTCoP) for infancy and childhood ...
Ando, Juko, Deno, Minako, Fujisawa, Keiko, K., Hiraishi, Kai, Kawamoto, Tetsuya, Kijima, Nobuhiko, Kobayashi, Kazuhiro, Murayama, Kou, Nozaki, Mari, Okada, Mitsuhiro, Ozaki, Koken, Sakagami, Masamichi, Sasaki, Shoko, Shikishima, Chizuru, Someya, Yoshiaki, Suzuki, Kunitake, Takahashi, Yusuke, Takizawa, Ryu, Tanaka, Mami, Toda, Tatsushi, Yamagata, Shinji   +20 more
core   +2 more sources

Effects of Arterial Stiffness and Carotid Intima-Media Thickness Progression on the Risk of Overweight/Obesity and Elevated Blood Pressure/Hypertension: a Cross-Lagged Cohort Study [PDF]

, 2021
Andrew O. Agbaje, Alan R. Barker, Tomi‐Pekka Tuomainen   +2 more
openalex   +1 more source